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Abstract
Human respiratory syncytial virus (HRSV) is a major cause of viral lower respiratory tract infections among infants and young
children. HRSV strains vary genetically and antigenically and have been classified into two broad subgroups, A and B (HRSV-
A and HRSV-B, respectively). To date, little is known about the circulating strains of HRSV in Latin America. We have
evaluated the genetic diversity of 96 HRSV strains by sequencing a variable region of the G protein gene of isolates
collected from 2007 to 2009 in Central and South America. Our results show the presence of the two antigenic subgroups of
HRSV during this period with the majority belonging to the genotype HRSV-A2.
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Introduction
Human respiratory syncytial virus (HRSV) is a respiratory
pathogen associated with substantial morbidity and mortality [1],
infecting nearly all children in the first two years of life and
hospitalizing 1% of those infected [2]. HRSV is one of the most
contagious human pathogens, comparable to the measles virus. In
one report the natural introduction of HRSV into a day-care setting
resulted in infection of more than 90% of infants and children [3].
The HRSV genome encodes the synthesis of at least 11 viral
proteins: three transmembrane glycoproteins known as the
attachment glycoprotein (G), the fusion protein (F), and the small
hydrophobic protein (SH); one matrix protein (M); two transcrip-
tion factors (M1 and M2); three proteins associated with the
nucleocapsid (N, P, and L); and two nonstructural proteins (NS1
and NS2) [4]. The F and G proteins are important antigenically
because they stimulate the production of protective immune
responses. Responses to the F protein include humoral and
cytotoxic T-lymphocyte responses [5].
HRSV strains vary genetically and antigenically and have been
classified into two broad subgroups:A and B (HRSV-A and
HRSV-B, respectively) [6–9]. Analyses of the sequences of the N,
P, SH, and G protein genes have confirmed the division of HRSV
into these two subgroups and also have identified numerous
genotypes or lineages within each subgroup [7,8,10–16]. Histor-
ically, the nomenclature assigned by Peret et al. [17,18] and
Venter et al. [19] for the different genotypes is: Protein Name-
Subgroup-Variant.
The G protein is of particular interest because variability in this
protein’s corresponding nucleotide sequence is greater than in
other proteins, both between and within the major antigenic
subgroups of HRSV [15,20,21]. By analogy to the other
paramyxoviruses and on the basis of experimental data, this
protein is presumed to be the attachment protein of HRSV [4],
and therefore, is very important, although not essential [22] for the
replication of the virus. Variability in the G protein gene is
concentrated in the extracellular domain, which consists of two
hyper-variable regions separated by a central conserved region of
13 amino acids [8]. The second variable region, which
corresponds to the C-terminal region of the G protein, reflects
overall G protein gene variability and has been analyzed in
molecular epidemiological studies [10,17]. The significance of
subgroup differentiation has been suggested by some studies. For
example, HRSV-A may be more virulent than HRSV-B, and
might result in greater disease severity among hospitalized infants
[23–25].
Information exists about the presence of HRSV in Latin
America [26–29] and a handful of reports describe the antigenic
diversity of strains in Argentina and Chile [30], but little is known
pertaining to the genetic diversity of this virus in the rest of the
region. Studies from Argentina found more HRSV-A than
HRSV-B during 2002 [31,32] and no other data has been
available since then.
In this study, we evaluated the genetic diversity of both HRSV-
A and HRSV-B strains by sequencing a variable region of the G
protein gene of isolates collected during a two and a half year
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Specimen Collection and Identification of HRSV Positive
Samples
In collaboration with nine Central and South American
countries (Nicaragua, Honduras, El Salvador, Venezuela, Colom-
bia, Ecuador, Bolivia, Peru, and Argentina) that are part of a
respiratory disease surveillance network, 15,875 pharyngeal swabs
specimens were collected at hospitals from participants, regardless
of age, with fever ($38uC) and cough or sore throat between
January 2007 and June 2009 [33]. Oropharyngeal swabs were
collected at all sites except for the sites in Nicaragua were
nasopharyngeal swabs collected. Swabs were transported in viral
transport media on dry ice to the Naval Medical and Research
Unit 6 (NAMRU-6) in Lima-Peru, where HRSV was identified by
immunofluorescence-confirmed culture. Table 1: shows the
number of samples from each country included in this study.
Virus isolation was carried out by inoculation into four cell lines
Madin-Darby canine kidney (MDCK), African green monkey
kidney (Vero76 and VeroE6) and Rhesus monkey kidney
(LLCMK2) cells (ATCC, Manassas, VA 20108). Upon the
appearance of a cytopathic effect (CPE) or after ten (or thirteen
in the case of Vero cells) days of culture, the cells were spotted onto
microscope slides. Cell suspensions were dried and fixed in chilled
acetone for 15 minutes. Immunofluorescence assay was performed
to identify the virus isolates from cell culture, using a direct
fluorescence assay (DFA). The Respiratory Virus Screening and
Identification Kit (D3 DFA Respiratory Virus Diagnostic Hybrids;
Athens, OH) was utilized for the identification of adenoviruses,
influenza A virus, influenza B virus, para-influenza viruses (types 1,
2, and 3), and HRSV. HRSV positive isolates obtained by DFA
were required for strain characterization.
Ethics
The study protocol was approved by the Naval Medical
Research Center Institutional Review Board (Protocol
NMRCD.2002.0019) in compliance with all applicable federal
regulations governing the protection of human subjects. All
participants underwent a verbal consent process. No informed
consent document was prepared since samples were obtained
through procedures considered less than minimal risk by the
aforementioned institutional review board.
RNA Extraction and RT-PCR
Viral RNA extraction was performed in a biosafety level-3
laboratory with enhanced containment practices. Nucleic acid was
extracted with the use of viral RNA kit (QIAamp, QiagenH) from
140 ml of the naso/oropharyngeal swabs and was amplified in a
reverse transcriptase PCR (RT-PCR). RT-PCR was performed by
using a SuperScript III One-Step RT-PCR System (Invitrogen;
San Diego, CA); 5 ml of extracted RNA was added to a master
mixture composed of an enzyme mixture (SuperScript III RT/
Platinum Taq), 3.2 mM MgSO4, and 0.4 mM dNTP. The G gene
primers were SHA (TCGAGTCAACACATAGCATTC) and F1
(CAACTCCATTGTTATTTGCC) [18]. This primer pair was
used at 20 mM in the amplification.
Five microliters of RNA were added to the 20 ml RT-PCR
master mixture. The amplification was carried out in a thermo-
cycler 7700 (Applied Bioystems; Foster City, CA). Cycling
conditions included a reverse transcription step at 50uC for 30
minutes and 94uC for 2 minutes followed by 40 PCR cycles: 94uC
for 30 seconds; 55uC for 30 seconds; 72uC for 1 minute, and final
incubation at 72uC for 7 minutes. The amplified product of
<1200 bp was analyzed by electrophoresis on a 2% agarose gel.
Phylogenetic Analysis
Phylogenetic trees were constructed on the basis of the G gene
sequence from 96 samples. For direct sequencing of viral nucleic
acids from HRSV culture-positive specimens, gene fragments were
amplified and sequenced with the use of the Big Dye terminator
cycle sequencing kit (version 3.1, Applied Biosystems) on a Genetic
Analyzer system (version 3130xL, Applied Biosystems). Gene
Table 1. Number of Samples by Country.
Country Total Samples HRSV Positive Sequenced
Argentina 845 20 15
Bolivia 477 10 3
Colombia 859 17 2
Ecuador 1,161 14 4
El Salvador 316 4 1
Honduras 621 5 -
Nicaragua 1167 94 32
Peru 9,916 130 37
Venezuela 514 2 2
Total 15,875 296 96
The number of total participants, HRSV-positive samples by
immunofluorescence, and the sequenced samples for each country.
doi:10.1371/journal.pone.0022111.t001
Figure 1. HRSV subgroups by Year. The number of samples for
each HRSV subgroup (A and B) per year. For years 2007 and 2008, the
month of collection are from January to December. For year 2009, the
months of collection are from January to June.
doi:10.1371/journal.pone.0022111.g001
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and BioEdit (version 7.0.0 -Isis Pharmaceuticals, Inc.) software.
All samples were classified into two distinct subgroups, named
HRSV-A and HRSV-B. The nucleotide sequences obtained
correspond to the extracellular region of the G protein, from
amino acid (aa) 24 to 221. This section includes the first variable
region of the G protein, the 13 aa conserved region in position
164-176 and a part of the second variable region of this protein.
The sequences were analyzed and aligned with the available
HRSV sequences from the GenBank database by using the
CLUSTAL X program (version 1.83). Phylogenetic trees were
constructed by the neighbor-joining method in MEGA software
(version 3). The statistical significance of the tree topology was
tested by bootstrapping (1,000 replicas). Pairwise distances
between and within the genotypes at the nucleotide level were
calculated with Kimura 2 parameters and with Poisson correction
at the amino acid level with MEGA software.
Results
Through the respiratory surveillance network, 15,875 samples
were collected from different countries in Central and South
America (Table 1). From those, 296 HRSV positive samples were
detected using DFA after cell culture was performed (Figure 1). In
agreement with previously published studies, 95% of HRSV
positive samples came from participants younger than 15 years old
Figure 2. HRSV subgroup A Phylogenetic Tree. 601 nucleotides of the G protein gene were amplified, sequenced, and compared to published
sequences from GenBank. We have labeled the samples according to the following format: ‘‘Sample code/Country of collection/Month- Year of
collection’’. The number of strains with identical sequences is shown in parenthesis to the right of one representative strain. The comparison
sequences are complete genome sequences from GenBank, these are presented in the following format: ‘‘Strain Number/GenBank Accession Number
in Bold’’. Nucleotide sequences were aligned by using Clustal X. Phylogenetic analyses were performed using the Kimura two-parameter model as a
model of nucleotide substitution and using the neighbor-joining method to reconstruct phylogenetic trees (MEGA version 2.1).
doi:10.1371/journal.pone.0022111.g002
Figure 3. HRSV subgroup B Phylogenetic Tree. 630 nucleotides of the variable region of G protein gene were amplified, sequenced, and
compared to published sequences from GenBank. Labeling and analysis were performed as in Figure 2.
doi:10.1371/journal.pone.0022111.g003
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adults older than 20 years old. Participants were 45% (n=133)
male and 55% (n=163) female, and this small difference was not
statistically significant.
Among the HRSV-infected patients, 100% presented with cough
and rhinorrhea, 46% had malaise, 37% experienced tearing, 30%
had sore throat, and 28% had wheezing. A total of 67 participants
(22.6%) were hospitalized and 28 (9.5%) were diagnosed with
pneumonia. From the 79 participants infected with HRSV-A, 18
(22.8%) were hospitalized. Conversely, none of the participants
infected with HRSV-B were hospitalized. Less common symptoms
included headache, eye pain, and muscular pain.
By immunofluorescence, we detected up to 19 co-infections
(6.4% of HRSV positive samples). The most common co-infecting
pathogens were adenovirus (n=7) and influenza A virus (n=6).
Co-infections with influenza B virus (n=2), HSV (n=2),
parainfluenza 3 virus (n=1) and echovirus (n=1) were also
detected.
From the 296 HRSV infections found, 96 HRSV were selected
randomly to be analyzed by sequencing. Nucleotide analysis
showed that both HRSV subgroups (A and B) circulated in Latin
America during the period of study (Figure 1). The obtained
sequences are available online in Genbank with accession
numbers: JF905487-JF905560.
Phylogenetic trees in Figure 2 and 3- show the diversity of the
samples upon analysis of their G protein gene nucleotide sequence
of HRSVA and -B respectively. The 79 HRSV-A samples (82.3%
of HRSV-positive samples) grouped clearly into two clades, GA2
and GA5, with GA2 accounting for 92% (n=73) of the samples
(Figure 2). In respect to the HRSV-B subgroup, the 17 samples
(17.7% of HRSV positive samples) grouped into only one clade
belonging to the BA [34] genotype (Figure 3).
Discussion
In this study, we investigated the genetic characteristics of
circulating HRSV virus in the regions of Central and South
America from January 2007 until June 2009, a time period prior to
the introduction of pandemic influenza. We detected 296 HRSV
cases by DFA accounting for 1.8% of all respiratory samples
received from the nine countries. There are many reports on the
different methods to detect HRSV [35–38], and the authors are
aware that immunofluorescence on cultured cells might not be the
most powerful technique to accomplish this, and therefore no
frequencies or proportions of HRSV infection will be discussed in
this manuscript. The aim of this study was to molecularly analyze
the circulating strains of HRSV in the region. Future studies
utilizing direct PCR may better address questions of frequency of
infection with this virus.
However, it was clear that the most affected population by
HRSV infection was children, in particular, children less than one
year old. We also showed that co-infection with other viruses is not
rare (6.4% of HRSV positive samples). Our findings differ from a
report of an outbreak of para-influenza 3 and HRSV [39] in that
we detected only one co-infection with these two viruses. Influenza
A and adenovirus were the two most common co-infections
detected in our patients with HRSV.
It is important to note that the proportion of hospitalization
among HRSV-infected patients was elevated compared to the
proportion among all recruited participants with ILI symptoms
(22.6% vs 5.1% with a p-value ,0.01). In agreement to what
others reported [23–25], we found that HRSV-A resulted in
greater disease severity than HRSV-B as shown by the
hospitalization rate of 22.8% for patients infected with HRSV-A
and zero for patients infected with HRSV-B. This difference is
statistically significant with a p-value ,0.05. Our results reveal the
presence of both HRSV-A and HRSV-B, as previously reported in
Argentina and Brazil [28,31,32].
Genetic variability was evident HRSV-A strains, with two main
sub-branches identified, corresponding to genotypes GA2 and
GA5. Our phylogenetic analysis revealed that GA2 was predom-
inant throughout the region compared to GA5 in the analyzed
strains.
In respect to HRSV-B, we were able to identified only one
strain featuring a 60-nucleotide insertion in the second variable
region of G protein, a BA-like strain. The BA genotype (named for
Buenos Aires [34]) was detected in Japan in 2003 [40] and
subsequently has been noted in China [41], Thailand [42], Japan
[43], South Africa [44], and India [21], becoming the predom-
inant HRSV-B genotype in circulation [45].
Together, these data provide a better understanding of the
HRSV strains in circulation in Latin America and show that
HRSV strains appear to be similarly distributed worldwide
[20,21,40,42–46].
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